D. E. Shaw & Co., Inc. Amerisourcebergen Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	38,600 Added 14.56%	303,800 $56.2 Million
Q2 2024 Aug 14, 2024	SELL	N/A	-14,300 Reduced 5.12%	265,200 $49.1 Million
Q1 2024 May 15, 2024	BUY	N/A	52,700 Added 23.24%	279,500 $51.7 Million
Q4 2023 Feb 14, 2024	BUY	$179.08 - $189.89 $18.2 Million - $19.3 Million	101,500 Added 81.01%	226,800 $42 Million
Q3 2023 Nov 14, 2023	BUY	$172.87 - $193.41 $21.7 Million - $24.2 Million	125,300 New	125,300 $22.6 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $165.73 $1.46 Million - $1.72 Million	-10,400 Reduced 73.76%	3,700 $523,000
Q1 2019 May 15, 2019	BUY	$73.37 - $86.85 $300,817 - $356,085	4,100 Added 41.0%	14,100 $1.12 Million
Q3 2018 Nov 14, 2018	BUY	$78.98 - $92.22 $789,800 - $922,200	10,000 New	10,000 $922,000

1,262

168M

7.52M

6.12M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.